4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-002934
Chief Accounting Officer sold 310 shares at $0.64 ($198)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-04 | Sale : show line 1 in the form | −310 | $0.64 | $198 | 97,190 | D |
| Open-market sales · 310 sh · avg $0.64 · $198 | ||||||
Loading xslF345X05/ownership.xml…